Telehealth Smoking Cessation for Quitting Smoking
(E-STOP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines the effectiveness of an online visit, or e-visit, in helping people quit smoking. Participants will be divided into two groups: one will use the Smoking cessation e-visit, which includes questionnaires about smoking habits and motivation to quit, while the other will receive standard advice and resources for quitting smoking. Some participants in the e-visit group may receive a prescription for a quit-smoking medication, though taking medication is not required. This trial suits current smokers who have smoked at least one cigarette a day for most of the past six months and have access to a smartphone and email. As an unphased trial, it offers a unique opportunity to explore innovative ways to quit smoking with flexible participation.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot have used an FDA-approved smoking cessation medication in the last 7 days before joining.
What prior data suggests that this electronic visit for smoking cessation is safe?
Research has shown that online tools for quitting smoking, such as the smoking cessation e-visit, can help people quit more effectively than some traditional methods. These tools are generally easy to use, and studies indicate they can increase quit rates without major safety concerns. While using nicotine products like e-cigarettes carries risks, the e-visit itself does not involve taking any specific medication. It primarily involves answering questions about smoking habits and preferences, which is safe. Participants may receive a prescription for a smoking cessation medication if desired, but it is not required. Based on current research, the e-visit itself is considered safe.12345
Why are researchers excited about this trial?
Researchers are excited about the Telehealth Smoking Cessation approach because it leverages electronic visits (e-visits) to enhance accessibility and convenience for individuals looking to quit smoking. Unlike traditional methods, which often require in-person visits and consultations, this method allows participants to receive guidance and support from the comfort of their home through digital means. This approach has the potential to reach more people, particularly those who may face barriers to accessing traditional healthcare settings. Additionally, the follow-up e-visit encourages sustained engagement, which could lead to higher success rates in quitting smoking.
What evidence suggests that this trial's treatments could be effective for quitting smoking?
Research shows that online visits can help people quit smoking. In this trial, participants in the "Smoking cessation electronic visit (e-visit)" arm will receive personalized online programs, which studies have found improve quit rates more than usual methods. A review of research has found that online tools and resources increase the chances of quitting smoking. This approach offers an easy and active way for people to get support in their efforts to stop smoking. Overall, early findings suggest that e-visits can be a promising tool in helping people quit smoking. Meanwhile, participants in the "Treatment as usual (TAU)" arm will receive information about the state quitline and recommendations to contact their PCP for further support.13678
Are You a Good Fit for This Trial?
This trial is for adults who smoke at least 5 cigarettes a day, are fluent in English, have daily email access, and own a smartphone. They must be enrolled or willing to enroll in MyChart with a valid address. It's not for those who've used FDA-approved quitting meds recently.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomly assigned to receive either the smoking cessation e-visit or not, with e-visits including questionnaires and potential prescriptions for smoking cessation medication.
Follow-up
Participants are monitored for smoking cessation outcomes, including medication adoption, treatment utilization, and smoking reduction.
What Are the Treatments Tested in This Trial?
Interventions
- Smoking cessation e-visit
- Treatment As Usual
Smoking cessation e-visit is already approved in United States for the following indications:
- Smoking cessation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
National Cancer Institute (NCI)
Collaborator